Labcorp Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Labcorp Holdings Inc.
- Former names
- Laboratory Corp of America Holdings National Health Laboratories Holdings Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 8071 — Services-Medical Laboratories
- Headquarters city
- Burlington
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LH
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000920148
- EIN
- 99-2588107
Board of directors
-
Adam H. Schechter · Director · President & CEOSince 2023
-
Carulla Victor Bulto · DirectorSince 2025
-
Dwight Gary Gilliland · DirectorSince 2023
-
Garheng Kong · DirectorSince 2023
-
Jean-Luc Belingard · DirectorSince 2023
-
Jeffrey A. Davis · DirectorSince 2023
-
John H. Sampson · DirectorSince 2026
-
Kathryn E. Wengel · DirectorSince 2023
-
Kerrii B. Anderson · DirectorSince 2023
-
Kirsten Marie Kliphouse · DirectorSince 2023
-
Paul Rothman · DirectorSince 2023
-
Peter M. Neupert · DirectorSince 2023
-
R. Sanders Williams · DirectorSince 2023
-
Richelle P. Parham · DirectorSince 2023
Chief executives
Adam H. Schechter
· President and CEO
Dates unknown
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
71.4%
-
92.5%
-
93.0%
-
93.5%
-
96.1%
-
99.5%
-
99.5%
-
99.9%
-
99.9%
-
100.0%
Board connections
9 of this board's directors also sit on 13 other boards.
- via Kerrii B. Anderson
- via Peter M. Neupert
- via R. Sanders Williams
- via Richelle P. Parham
- via Adam H. Schechter
- via Jeffrey A. Davis
- via Peter M. Neupert
- via Kirsten Marie Kliphouse
- via Paul Rothman
- via R. Sanders Williams
- via Kerrii B. Anderson
- via Kerrii B. Anderson
- via Garheng Kong
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $13,702,854
- 21 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Kerrii B. Anderson Director | Open-market sale | −3,000 | $318.02 | $954,060 |
| Aug 11, 2026 | Adam H. Schechter Director, Officer (President & CEO) | Open-market sale | −4,669 | $320.37 | $1,495,808 |
| Aug 4, 2026 | Summy Amy B. Officer (EVP, Chief Marketing Officer) | Open-market sale | −924 | $306.74 | $283,428 |
| Aug 3, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Open-market sale | −82 | $309.22 | $25,356 |
| Aug 3, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Option exercise | +1,338 | $209.25 | $279,977 |
| Aug 3, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Open-market sale | −1,338 | $309.23 | $413,751 |
| Jul 2, 2026 | Kyle Kathryn W Officer (EVP, Chief Legal Officer) | Open-market sale | −92 | $286.19 | $26,329 |
| Jul 2, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Open-market sale | −234 | $286.19 | $66,968 |
| Jul 1, 2026 | Kyle Kathryn W Officer (EVP, Chief Legal Officer) | Option exercise | +256 | — | — |
| Jul 1, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Option exercise | +327 | — | — |
| Jul 1, 2026 | Kyle Kathryn W Officer (EVP, Chief Legal Officer) | Shares withheld for tax | −73 | $283.88 | $20,723 |
| Jul 1, 2026 | Vaughn Bryan T Officer (EVP and President, Diagnostics) | Shares withheld for tax | −93 | $283.88 | $26,401 |
| Jun 8, 2026 | Kyle Kathryn W Officer (EVP, Chief Legal Officer) | Open-market sale | −762 | $263.89 | $201,084 |
| May 11, 2026 | Adam H. Schechter Director, Officer (President & CEO) | Open-market sale | −5,903 | $254.50 | $1,502,314 |
| Mar 27, 2026 | Wilkinson Peter J Officer (SVP, Chief Accounting Officer) | Open-market sale | −1,633 | $267.05 | $436,093 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.